Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

ABT

Abitare In (ABT)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
DataOraFonteTitoloSimboloCompagnia
09/07/200820:30PR Newswire (US)Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting StentBIT:ABT
02/07/200823:19PR Newswire (US)FDA Approves Abbott's XIENCE(TM) V Drug Eluting StentBIT:ABT
24/06/200815:32PR Newswire (US)Abbott and Partnership for a Drug-Free America Launch 'Not In My House' to Help Parents Secure Their Homes from Teen PrescriptioBIT:ABT
13/06/200808:00PR Newswire (US)New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid ArthritisBIT:ABT
02/06/200822:56PR Newswire (US)American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community InitiativesBIT:ABT
28/05/200816:01PR Newswire (US)Abbott to Present at Goldman Sachs Global Healthcare ConferenceBIT:ABT
16/05/200807:02PR Newswire (US)Abbott Launches Next-Generation StarClose(R) SE Vascular Closure SystemBIT:ABT
01/05/200815:00PR Newswire (US)Abbott, Takeda Conclude TAP Joint VentureBIT:ABT
24/04/200816:03PR Newswire (US)Abbott Announces Labs Are Vital(TM) Facebook Scholarship Contest WinnersBIT:ABT
19/03/200821:09PR Newswire (US)Takeda, Abbott Announce Plans to Conclude TAP Joint VentureBIT:ABT
15/02/200822:55PR Newswire (US)Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive CholesteroBIT:ABT
13/02/200818:51PR Newswire (US)On Valentine's Day, Abbott Urges Women to Take Heart With Launch of 'Faces of Heart Disease' Exhibit to Raise Heart Health AwareBIT:ABT
01/12/200718:29PR Newswire (US)Cookie Johnson and Abbott Bring 'I Stand With Magic: Campaign to End Black AIDS' to Los Angeles to Educate African-American WomeBIT:ABT
01/12/200711:00PR Newswire (US)Ugandan Children Are Among the First to Receive Abbott's Lower-Strength Aluvia (lopinavir/ritonavir) TabletBIT:ABT
27/11/200717:08PR Newswire (US)Abbott to Present Comprehensive Safety and Efficacy Data on XIENCE(TM) V Drug Eluting Stent to FDA Advisory Committee on Nov. 29BIT:ABT
21/11/200717:47PR Newswire (US)Abbott's Environmental Protection Initiatives Again Recognized by the State of IllinoisBIT:ABT
21/11/200716:39PR Newswire (US)Abbott Employees Give Back to Local Communities This Holiday SeasonBIT:ABT
12/11/200719:15PR Newswire (US)Abbott Receives U.S. Food and Drug Administration Approval for New Lower-Strength Kaletra(R) (lopinavir/ritonavir) Tablet for PeBIT:ABT
08/11/200714:03PR Newswire (US)New Web Site Tools Help Alleviate Stress Associated with Caring for Children with Diabetes During the HolidaysBIT:ABT
29/10/200716:01PR Newswire (US)Abbott Employees Provide Healthy Treats to Ghosts and Goblins Across United StatesBIT:ABT
17/10/200713:42PR Newswire (US)Abbott Reports 14.4 Percent Sales Growth in Third QuarterBIT:ABT
10/10/200714:01PR Newswire (US)Abbott Named One of the Best Companies for Hispanics by Hispanic Business MagazineBIT:ABT
25/09/200713:01PR Newswire (US)Abbott Again Honored as Top Company for Working MomsBIT:ABT
13/09/200715:15PR Newswire (US)Abbott Awards Arizona Mother $135,000 in National Similac(R) ContestBIT:ABT
31/08/200715:01PR Newswire (US)Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose CombinationBIT:ABT
29/06/200700:36PR Newswire (US)Abbott and Abbott Fund Expand Commitment to Improving Health Care in Tanzania With Dedication of New Lab and Launch of New DiagnBIT:ABT
13/06/200715:15PR Newswire (US)Global Business Coalition on HIV/AIDS, TB and Malaria (GBC) Honors Abbott and Abbott Fund for Efforts to Fight HIV/AIDS in TanzaBIT:ABT
12/06/200721:25PR Newswire (US)Abbott to Present at Goldman Sachs Healthcare ConferenceBIT:ABT
04/06/200717:36PR Newswire (US)First Bright Space Developed to Give Children Living With Substance Abuse a Dedicated Play and Learning EnvironmentBIT:ABT
27/04/200713:27PR Newswire (US)Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn.s DiseaseBIT:ABT
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:ABT
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network